LifeCare Partners
Basel, Switzerland
10
10M
7
4
0.30
2
- Stages of investment
- Areas of investment
Summary
The company was established in Europe in Switzerland. The main office of represented Corporate Investor is situated in the Basel.
The typical case for the fund is to invest in rounds with 4 participants. Despite the LifeCare Partners, startups are often financed by VI Partners AG, VINCI CAPITAL, Reference Capital SA. The meaningful sponsors for the fund in investment in the same round are Life Sciences Partners, Omega Funds, Bayern Kapital GmbH. In the next rounds fund is usually obtained by bmp Ventures, Omega Funds, Life Sciences Partners.
The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. This LifeCare Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2015.
We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Kuros Biosciences, Immunic. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 4
- Exits
- 2
- Follow on index
- 0.30
- Investments by industry
- Biotechnology (7)
- Medical (5)
- Health Care (5)
- Life Science (3)
- Therapeutics (3) Show 7 more
- Investments by region
-
- United States (3)
- Germany (4)
- Switzerland (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.90
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
NeoPrediX | 17 Mar 2021 | Health Care, Medical Device | Early Stage Venture | 4M | Bavaria, Regensburg, Germany |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.